CURE Pharmaceutical [OTCQB:CURR] Secures Patent on Oral Thin Films With Bi-Phasic Release of Natural Ingredients
July 16, 2019 07:25 ET
|
Cure Pharmaceutical Holding Corp.
OXNARD, Calif., July 16, 2019 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC:CURR), an innovative drug delivery and development company, today announced the allowance of U.S. Application No....
CURE Pharmaceutical [OTCQB:CURR] and Canopy Growth to Produce CBD Oral Thin Films
June 19, 2019 07:25 ET
|
Cure Pharmaceutical Holding Corp.
OXNARD, Calif. , June 19, 2019 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, today announced it is collaborating with Canopy Growth...
CURE Pharmaceutical (OTCQB:CURR) Closes Acquisition Of Privately-Held Chemistry Holdings Inc.
May 14, 2019 09:25 ET
|
Cure Pharmaceutical Holding Corp.
OXNARD, Calif., May 14, 2019 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR) (“CURE”), an innovative drug delivery and development company, today announced that it has closed on the previously...
Meroven LLC and CURE Pharmaceutical Enter Exclusive Marketing and Distribution Agreement for Spee-D for the USA
May 02, 2019 07:25 ET
|
Cure Pharmaceutical Holding Corp.
CHICAGO, May 02, 2019 (GLOBE NEWSWIRE) -- Today, at the CPhI Conference, Meroven LLC announced a five-year agreement with CURE Pharmaceutical Corporation (OTCQB: CURR) to exclusively market and...
CURE Pharmaceutical Announces Completion of FDA Pre-IND Review and Clinical Trial Plans for CUREfilm Blue™ for Erectile Dysfunction
March 26, 2019 07:25 ET
|
Cure Pharmaceutical Holding Corp.
OXNARD, Calif., March 26, 2019 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, today announced it has successfully completed a pre-IND...
Fuisz Pharma LLC Announces Notice of Patent Allowance for its System of Custody and Control for Abusable Drugs: Blockchain like HIPPA Compliant Technology Applies Custody and Control Parameters to Unit Dose Packaged Drugs
November 09, 2018 07:45 ET
|
Fuisz Pharma LLC
Miami, FL, Nov. 09, 2018 (GLOBE NEWSWIRE) -- Fuisz Pharma LLC announced today that it has received a Notice of Allowance from the United States Patent Office in connection with its patent...
Fuisz Pharma LLC Announces Allowance of Additional Patent Claims for its New Film by Deposit Technology Platform
October 08, 2018 07:45 ET
|
Fuisz Pharma LLC
Miami, FL, Oct. 08, 2018 (GLOBE NEWSWIRE) -- Fuisz Pharma LLC (Fuisz) announced today the allowance of additional patent claims for its Film by Deposit Technology Platform. Fuisz previously...
Update: Fuisz Pharma Announces Issuance of Oral Thin Film Pharmaceutical Patent (re-release)
March 05, 2018 10:30 ET
|
Fuisz Pharma LLC
Miami, FL, March 05, 2018 (GLOBE NEWSWIRE) -- Fuisz Pharma LLC announced today the issuance of a new patent, US 9,901,545 (the “’545 Patent”) concerning the manufacture of oral thin film...
Fuisz Pharma Announces Issuance of Oral Thin Film Pharmaceutical Patent
March 05, 2018 07:30 ET
|
Fuisz Pharma LLC
Miami, FL, March 05, 2018 (GLOBE NEWSWIRE) -- Fuisz Pharma LLC announced today the issuance of a new patent, US 9,901,545 (the “’545 Patent”) concerning the manufacture of oral thin film...
Oak Therapeutics Announces Results of Bioequivalence Study of Company’s Oral Dissolvable Strip for Tuberculosis
October 03, 2017 09:00 ET
|
CURE Pharmaceutical
OXNARD, Calif., Oct. 03, 2017 (GLOBE NEWSWIRE) -- Oak Therapeutics, a subsidiary of CURE Pharmaceutical (OTCQB:CURR), (“CURE”), a leading disruptive drug delivery technology company, has completed...